⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ODAIA and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
ODAIA
↗Toronto, Canada
ODAIA is a Toronto-based enterprise AI software-as-a-service (SaaS) company that provides commercial intelligence and customer journey mapping for the pharmaceutical and life sciences industries. Its flagship platform, MAPTUAL, leverages artificial intelligence, machine learning, and process mining to analyze disparate data sources—including claims, lab data, and CRM logs—to help commercial teams segment healthcare providers, predict prescribing behavior, and optimize omnichannel engagement strategies.
Founded in 2018 as a spin-out from the University of Toronto's UTEST program, the company focuses on solving the 'bottleneck' in pharmaceutical commercialization. By transforming manual, labor-intensive sales processes into data-driven, real-time insights, ODAIA enables biopharmaceutical companies to improve their go-to-market efficiency and patient outcomes.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Commercial Intelligence SaaS for Pharma
SIZE & FINANCIALS
Employees:51-200
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$25M USD
Investors:Threshold Ventures, Monograph Capital, Wittington Ventures, Flint Capital, BDC Capital's Women in Technology Venture Fund, StandUp Ventures, Graphite Ventures
0
CORPORATE STRUCTURE
Key Partnerships:Top 20 global pharmaceutical companies (clients)
COMPETITION
Position:Emerging
Competitors:Veeva Systems, IQVIA, ZS Associates, Aktana
LEADERSHIP
Key Executives:
Philip Poulidis - CEO & Co-Founder
Helen Kontozopoulos - Co-Founder
Andrew Gunn - Chief Commercial Officer
Rebecca Skvorc - Chief Financial Officer
Scientific Founders:Philip Poulidis, Helen Kontozopoulos, Periklis Andritsos
Board Members:Emily Melton (Threshold Ventures), Charles Conn (Monograph Capital), Michael Cloutier (Former CEO, AstraZeneca Canada)
LINKS
Website:odaia.ai
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ODAIA. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.